IMRX
Immuneering CorpCompany with tickers: IMRX
CIK
1790340
CUSIP
45254E107
Shares Outstanding
64,697,402
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $15,484,652 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $11,471,693 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-15,484,652 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-15,046,132 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.42 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.42 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |